Adn-319-en-javhd-today-07072101-45-02 Min New! Jun 2026

: Briefly introduce the content. If it's an adult video, mention the main actors if their names are available and any notable production aspects.

| Item | Description | |------|-------------| | | ADN‑319 – oral small‑molecule inhibitor of adenosine deaminase (ADA). | | File Identifier | 07072101‑45‑02 Min – indicates a 45‑minute video recorded on 01 July 2021, released on 07 July 2021. | | Format | JAVHD (Java‑based High‑Definition video) – used for internal stakeholder briefings and external scientific webinars. | | Target Indications | Autoimmune inflammatory diseases (RA, SLE, PsA) and potential off‑label use in COVID‑19 cytokine storm (exploratory). | | Sponsor | NeuroAdeno Therapeutics Ltd. (NASDAQ: NADT). | | Current Development Stage | Completed Phase I (single ascending dose, MAD) – safety & PK/PD established. Ongoing Phase IIb (N=210). | ADN-319-EN-JAVHD-TODAY-07072101-45-02 Min